Selected Publications

Worthington J, Robson T, O’Keeffe M and Hirst DG (2001) Tumour cell radiosensitisation using a constitutive (CMV) and radiation inducible promoter (WAF1) to drive the iNOS gene; a novel suicide gene therapy. Gene Ther (in press).

Gallagher R, Hughes CM, Murray MM, Friery OP, Patterson LH, Hirst DG, McKeown SR.The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N. Br J Cancer. 2001 Aug 17; 85(4): 625-9.

Al-Assar O, Robson T, McKeown SR, Gardin I, Wilson GD, Hirst DG. Regulation of FOS by different compartmental stresses induced by low levels of ionizing radiation. Radiat Res. 2000 Nov;154(5):503-14.

Worthington J, Robson T, Murray M, O'Rourke M, Keilty G, Hirst DG. Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Ther. 2000 Jul; 7(13):1126-31.

Ruddock MW, Burns DM, McKeown SR, Murphy L, Walsh IK, Keane PF, Hirst DG. Contractile properties of human renal cell carcinoma recruited arteries and their response to nicotinamide. Radiother Oncol. 2000 Feb; 54(2): 179-84.